1.  Synthesis of Biologically active resin glycosides and evaluation of their anti-cancer properties: Department of Science and Technology (SR/FTP/CS-110/2005); Rs. 15,24,000.00; Completed

​

2.  Synthesis of the oligosaccharides related to the repeating units of the O-antigens from Shigella boydii type-16 and type-17 and further vaccine designing: Department of Science and Technology (SR/S1/OC-67/2009); Rs. 23,00,000.00, Completed

 

3.  Synthesis hexasaccharide repeating unit of the O-antigen from E. coli O35 and a tetrasaccharide related to the capsular polysaccharide repeating unit of Vibrio cholerae serogroup O31 NRT36S: Council for Scientific and Industrial Research [01(2370)/10/EMR-II], Rs. 10,00,000.00, Completed

 

4.  Synthesis of galactose-hetereocycle hybrids as novel anti-inflammatory and anti-tumor agents and of glyconanoparticles as galectin targeting tumor markers: Swedish Research Council (Dnr 348-2007 6856); Rs. 12,07,155.00, Completed

 

5.  Synthesis of the oligosaccharides related to the repeating units of the O-antigens from E. coli O158, O36 AND O174 and further vaccine designing: Scientific and Engineering Research Board (SB/S1/OC 48/2013); Rs. 26,00,000.00, Completed

 

6.  Synthesis of the complex oligosaccharides related to the O-antigens from E. coli O74, O145 and O156 with the scope for further glyco-conjugates and vaccine designing: Scientific and Engineering Research Board (EMR/2017/003043); Rs. 37,34,500.00, Completed

 

7.  Chemical Synthesis of the Oligosaccharides Related to the Capsular Polysaccharides from Acinetobacter baumannii Strains for Potential Vaccine Development: Scientific and Engineering Research Board (CRG/2022/005805); Rs. 61,79,888.00, Completed